CDC official in charge of Covid data resigns ahead of vaccine meeting
Dr Fiona Havers told colleagues in an email that she no longer had confidence the data would be used 'objectively or evaluated with appropriate scientific rigor to make evidence-based vaccine policy decisions', according to Reuters.
She resigned before a planned meeting of a new vaccine panel put in place by Robert Kennedy Jr after he fired all 17 members of the CDC's independent vaccine advisory panel. Kennedy also dropped a recommendation to get the Covid shot for healthy children and pregnant women.
Havers, leader of the Resp-Net hospitalization surveillance team, did not respond to requests for comment.
Her resignation follows moves by Kennedy, the health secretary, to abruptly fire all 17 members of the CDC's independent vaccine advisory panel and drop a recommendation for administering Covid shots to healthy children and pregnant women.
Kennedy, who has long sown doubt about the safety and efficacy of vaccines, replaced the advisory board with eight members of his own choosing, some of whom have histories of objecting to Covid shots or vaccines in general.
Havers said in her email that the Covid and RSV data collected by her team had been used in more than 20 peer-reviewed manuscripts and 15 Morbidity and Mortality Weekly Reports issued by the CDC.
The newly installed vaccine panel, known as the advisory committee on immunization practices, is expected to meet 25-27 June to vote on the use of Covid-19 boosters and other vaccines by the American public.
A Health and Human Services spokesperson told Reuters that the agency is committed to 'gold standard science' and that the vaccine policy will be based on objective data, transparent analysis and evidence.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
8 minutes ago
- The Independent
4 people die in crash of medical transport plane on Navajo Nation in northern Arizona
A small medical transport plane crashed and caught fire Tuesday on the Navajo Nation in northern Arizona, killing four people, the tribe said in a statement. A Beechcraft 300 from the CSI Aviation company left Albuquerque, New Mexico, with four medical personnel on board, according to the Federal Aviation Administration and other agencies. It crashed in the early afternoon near the airport in Chinle, about 300 miles (483 kilometers) northeast of Phoenix. 'They were trying to land there and unfortunately something went wrong,' district Police Commander Emmett Yazzie said. The crew was planning pick up a patient who needed critical care from the federal Indian Health Service hospital in Chinle, said Sharen Sandoval, director of the Navajo Department of Emergency Management. She said the plan was to return to Albuquerque. The patient's location and condition were not known Tuesday evening. Tribal authorities began receiving reports at 12:44 p.m. of black smoke at the airport, Sandoval said. The cause of the crash wasn't known, the tribe said. The National Transportation Safety Board and the FAA are investigating. Navajo Nation President Buu Nygren said in a social media post that he was heartbroken to learn of the crash. 'These were people who dedicated their lives to saving others, and their loss is felt deeply across the Navajo Nation,' he said. Medical transports by air from the Navajo Nation are common because most hospitals are small and do not offer advanced or trauma care. The Chinle airport is one of a handful of airports that the tribe owns and operates on the vast 27,000 square-mile (70,000 square-kilometer) reservation that stretches into Arizona, New Mexico and Utah -- the largest land base of any Native American tribe. In January, a medical transport plane crashed in Philadelphia, killing eight people. The National Transportation Safety Board, which is investigating the crash, has said the voice recorder on that plane was not working. ___ Associated Press journalists Hannah Schoenbaum in Salt Lake City and Felicia Fonseca in Flagstaff, Arizona, contributed to this report.
Daily Mirror
9 minutes ago
- Daily Mirror
Chikungunya: Everything we know about deadly virus spreading through China
The chikungunya virus, which is spread by mosquitoes, is rarely fatal but has seen a surge in cases in China after an imported case was detected in Foshan city earlier this month A mosquito-borne virus outbreak has infected more than 7,000 people across at least 13 cities in China, prompting authorities to introduce strict precautions reminiscent of the COVID pandemic - even though the virus cannot be transmitted from person to person. The chikungunya virus, which is only spread through the bite of an infected mosquito and is rarely fatal, has swept rapidly through more than a dozen cities in southern Guangdong province, just north of Hong Kong. Nearly 3,000 cases were reported in the past week alone, according to the BBC. Chikungunya is typically uncommon in China, but infections soared after an imported case was detected in Foshan city on July 8, which has since become the worst-affected area, according to the New York Times. The news comes since reports that the disease could arrive in the UK. In response, authorities in Guangdong have implemented measures similar to those deployed during the COVID pandemic. All infected patients are required to remain in hospital isolation under a mosquito net until they test negative for the virus, according to a translation of Chinese news outlet NF News. Officials are also carrying out door-to-door inspections to ensure stagnant water - where mosquitoes breed - is eliminated. Those who fail to comply can be fined or face criminal charges for "obstructing the prevention of infectious diseases," according to a government flyer translated by the Times, reports the Express. Other measures include the introduction of giant "elephant mosquitoes", whose larvae consume virus-carrying mosquitoes, releasing mosquito-eating fish into local ponds, spraying pesticides and using drones to identify mosquito breeding sites, according to The Times. What is chikungunya? Chikungunya is a mosquito-borne virus that typically causes symptoms such as headache, muscle pain, nausea, fatigue, rash and swollen joints. While most symptoms resolve within two weeks, the "debilitating" joint pain can persist for months or even years, says the World Health Organisation. This joint pain is considered the hallmark symptom of chikungunya. Without it, infected individuals may be misdiagnosed with dengue or Zika, making it challenging to determine how many people actually have chikungunya. First identified in southern Tanzania in the 1950s, its name derives from a Kimakonde word meaning "that which bends up," describing the contorted posture caused by severe joint pain. How does it spread? Chikungunya can only be transmitted via a mosquito bite. However, individuals with the virus can pass it back to non-infected mosquitoes if bitten, allowing those insects to then infect others. The virus is not contagious between humans. Is there a vaccine? There are two vaccines approved for use in the United States: IXCHIQ (for those 18 and older) and VIMKUNYA (for those 12 and older). The CDC recommends vaccination only for travellers heading to areas with active chikungunya outbreaks. Where is chikungunya most common? The Centers for Disease Control and Prevention have issued a warning to U.S. travellers visiting Brazil, Colombia, India, Mexico, Nigeria, Pakistan, Thailand and the Philippines, stating they are at an increased risk. A Level 2 travel alert has also been issued for Foshan city, with the CDC recommending that travellers get vaccinated before their visit. Preventive measures include using insect repellent and wearing long-sleeved shirts and trousers. Pregnant women are advised against travelling to affected regions. What's next? Authorities are bracing for more infections after Hong Kong reported its first case - a 12 year old lad - on Monday.
The Guardian
an hour ago
- The Guardian
OpenAI stops ChatGPT from telling people to break up with partners
ChatGPT will not tell people to break up with their partner and will encourage users to take breaks from long chatbot sessions, under new changes to the artificial intelligence tool. OpenAI, ChatGPT's developer, said the chatbot would stop giving definitive answers to personal challenges and would instead help people to mull over problems such as potential breakups. 'When you ask something like: 'Should I break up with my boyfriend?' ChatGPT shouldn't give you an answer. It should help you think it through – asking questions, weighing pros and cons,' said OpenAI. The US company said new ChatGPT behaviour for dealing with 'high-stakes personal decisions' would be rolled out soon. OpenAI admitted this year that an update to ChatGPT had made the groundbreaking chatbot too agreeable and altered its tone. In one reported interaction before the change, ChatGPT congratulated a user for 'standing up for yourself' when they claimed they had stopped taking their medication and left their family – who the user had thought were responsible for radio signals emanating from the walls. In the blog post, OpenAI admitted that there had been instances where its advanced 4o model had not recognised signs of delusion or emotional dependency – amid concerns that chatbots are worsening people's mental health crises. The company said it was developing tools to detect signs of mental or emotional distress so ChatGPT can direct people to 'evidence-based' resources for help. A recent study by NHS doctors in the UK warned that AI programs could amplify delusional or grandiose content in users vulnerable to psychosis. The study, which has not been peer reviewed, said the programs' behaviour could be because the models were designed to 'maximise engagement and affirmation'. The study added that even if some individuals benefited from AI interactions, there was a concern the tools could 'blur reality boundaries and disrupt self-regulation'. OpenAI added that from this week it would send 'gentle reminders' to take a screen break to users engaging in long chatbot sessions, similar to screen-time features deployed by social media companies. OpenAI also said it had convened an advisory group of experts in mental health, youth development and human-computer-interaction to guide its approach. The company has worked with more than 90 doctors, including psychiatrists and paediatricians, to build frameworks for evaluating 'complex, multi-turn' chatbot conversations. 'We hold ourselves to one test: if someone we love turned to ChatGPT for support, would we feel reassured? Getting to an unequivocal 'yes' is our work,' said the blog post. The ChatGPT alterations were announced amid speculation that a more powerful version of the chatbot is imminent. On Sunday Sam Altman, OpenAI's chief executive, shared a screenshot of what appeared to be the company's latest AI model, GPT-5.
